Literature DB >> 10657020

Integration and proliferation of transplanted cells in hepatic parenchyma following D-galactosamine-induced acute injury in F344 rats.

S Gupta1, P Rajvanshi, A N Irani, C J Palestro, K K Bhargava.   

Abstract

To determine whether liver repopulation with cell transplantation could be of therapeutic value in acute hepatic failure, it is necessary to establish the fate of transplanted hepatocytes. This study used dipeptidyl peptidase IV-deficient F344 rats as recipients to analyse the engraftment and proliferation of transplanted hepatocytes. Syngeneic hepatocytes were transplanted intrasplenically 24-30 h after induction of liver injury by D-galactosamine (GalN). Portosystemic shunting was analysed with 99m-Tc-labelled albumin microspheres. GalN-treated rats showed characteristic hepatic necrosis, inflammation, gamma-glutamyl transpeptidase activation, and regenerative activity, without increased portosystemic shunting (>99% 99m-Tc activity was in the liver in normal and GalN-treated rats). Transplanted cells entered hepatic sinusoids promptly and were observed in liver plates at 48 h. The number of transplanted cells increased in GalN-treated rats by approximately seven-fold (range two- to 12-fold), along with evidence for DNA synthesis between 3 and 14 days after cell transplantation and greater prevalence of larger transplanted cell clusters. These findings indicate that the liver can be safely repopulated in animals with acute liver failure, although the time required for regenesis of plasma membrane structures and proliferation in transplanted hepatocytes will need to be considered in developing therapeutic strategies. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657020     DOI: 10.1002/(SICI)1096-9896(200002)190:2<203::AID-PATH521>3.0.CO;2-2

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

1.  Human amniotic fluid-derived stem cells can differentiate into hepatocyte-like cells in vitro and in vivo.

Authors:  Hui Liu; Da-qing Liu; Bao-wei Li; Li-dong Guan; Zhi-feng Yan; Ya-li Li; Xue-tao Pei; Wen Yue; Min Wang; Yan-ping Lu; Hong-mei Peng; Yang Lv
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-09-22       Impact factor: 2.416

2.  Diminution of toxic copper accumulation in toxic milk mice modeling Wilson disease by embryonic hepatocyte intrasplenic transplantation.

Authors:  Zhu Shi; Xiu-Ling Liang; Bing-Xun Lu; Su-Yue Pan; Xi Chen; Qi-Qiang Tang; Ying Wang; Fan Huang
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 3.  Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.

Authors:  Mukaddes Esrefoglu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

4.  Etanercept blocks inflammatory responses orchestrated by TNF-α to promote transplanted cell engraftment and proliferation in rat liver.

Authors:  Preeti Viswanathan; Sorabh Kapoor; Vinay Kumaran; Brigid Joseph; Sanjeev Gupta
Journal:  Hepatology       Date:  2014-09-09       Impact factor: 17.425

5.  Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo.

Authors:  G Nowak; B-G Ericzon; S Nava; M Jaksch; M Westgren; S Sumitran-Holgersson
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

6.  New directions for cell-based therapies in acute liver failure.

Authors:  Preeti Viswanathan; Sanjeev Gupta
Journal:  J Hepatol       Date:  2012-06-16       Impact factor: 25.083

7.  Perturbations in ataxia telangiectasia mutant signaling pathways after drug-induced acute liver failure and their reversal during rescue of animals by cell therapy.

Authors:  Sriram Bandi; Brigid Joseph; Ekaterine Berishvili; Rohit Singhania; Yao-Ming Wu; Kang Cheng; Sanjeev Gupta
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

8.  Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model.

Authors:  Brigid Joseph; Sorabh Kapoor; Michael L Schilsky; Sanjeev Gupta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

9.  Cell-based therapy for acute and chronic liver failures: distinct diseases, different choices.

Authors:  Kai Sun; Xuqin Xie; Jing Xie; Shufan Jiao; Xiaojing Chen; Xue Zhao; Xin Wang; Lixin Wei
Journal:  Sci Rep       Date:  2014-09-29       Impact factor: 4.379

10.  The nude mouse as model for liver deficiency study and treatment and xenotransplantation.

Authors:  Isabelle Vidal; Lysiane Richert
Journal:  Int J Hepatol       Date:  2012-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.